Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tri Fluvac Immunogenicity and Safety in Healthy Thai Adults
NCT03390166Phase 3Completed
- Sponsor
- Mahidol University
- Start
- Jul 2017
- Primary completion
- Mar 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Tri Fluvac in influenza, sponsored by Mahidol University. Started Jul 2017; status: completed.
02
Drugs
Tri Fluvac
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03390166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03390166.